Advertisement
RNXT Novinky na Forexu
RenovoRx Appoints James Ahlers To Succeed Christopher Lehman As CFO
Biopharmaceutical company RenovoRx, Inc. (RNXT) announced Tuesday the appointment of James Ahlers as Chief Financial Officer (CFO), effective July 15, 2022. Ahlers replaces Christopher Lehman, who joined RenovoRx in connection with its initial public offering and is leaving to pursue a new business opportunity.
RTTNews
|
Před 1068 dny
